FDA approves UCB’s Keppra XR
BRUSSELS, Belgium The Food and Drug Administration has approved UCB’s epilepsy drug Keppra XR, the Belgian drug maker announced Monday.
The FDA approved the drug as an add-on treatment for partial-onset seizures in patients aged 16 and older. It is an extended-release version of the drug Keppra.
Keppra (levetiracetam) will lose patent protection in November, while the new version will remain protected until 2011.
Retail clinic care professionals can help patients avoid sports injuries
BETHESDA, Md. The 2008-2009 football season is gearing up so those working within retail-based health clinics should not only watch for more sports injuries but also help patients protect themselves by offering preventative tips.
According to the American Podiatric Medical Association, both professional and amateur athletes are at an extremely high risk for injuring their lower limbs during play.
“Stress fractures of the foot, ankle sprains and ligament injuries are all, unfortunately, quite common in popular fall sports such as football,” stated David Davidson, APMA member and podiatric medical consultant for the Buffalo Bills of the NFL. “From maintaining proper conditioning to wearing sport-specific footwear, athletes can function at peak performance much more often when constantly maintaining high levels of foot care safety.”
Tips to help avoid sprains, fractures and turf toe include:
- To help avoid sprains take part in proper warm-up exercises before and after home workouts, practice and games. Spend five to 10 minutes stretching, holding and relaxing muscles.
- To help avoid fractures look for sport-specific footwear that contains extra padding in cleated shoes, which helps to prevent stress fractures—incomplete fractures in bones are typically caused by overuse.
- To help avoid turf toe wear a stiffer shoe so prevent aggravating the injury further. Customized foot orthotics may also be worn during play to protect against turf toe.
Teen smokers reject nicotine nasal spray
NEW YORK A study published in the journal Pediatrics suggests that teenagers are not more likely to quit smoking if they use nicotine nasal spray.
Teenagers using the spray, which usually works in adults, complained of side effects such as burning in the nostrils, foul smells and others and stopped using it altogether or didn’t use it often enough.
Other treatments often didn’t work either. Nicotine patches, for example, gave doses too large, leading to jumpiness and nightmares, but doses still didn’t relieve nicotine cravings.
The study involved 40 teenagers aged 15 to 18 who smoked at least five cigarettes a day over the previous six months. The teenagers were divided into groups who received eight weeks of counseling, six weeks of the spray or a combination of the two treatments. The researchers found no difference between the groups that received the counseling only and the counseling plus the spray. Among those who received the spray only, 57 percent stopped after a week.